Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,35 USD | +4,69% |
|
-.--% | -.--% |
Attività
Numero di dipendenti: 423
Vendite per attività
USD in Milioni | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
Human Medicines and Medical Supplies
73,7
%
| 18 | 77,3 % | 23 | 73,7 % | +27,28% |
Manufacturing Services
15,2
%
| 4 | 15,2 % | 5 | 15,2 % | +33,09% |
Veterinary Medicines
3,4
%
| 1 | 3,7 % | 1 | 3,4 % | +23,06% |
License Fee
3,3
%
| - | - | 1 | 3,3 % | - |
Other Services
2,1
%
| 1 | 2,2 % | 1 | 2,1 % | +25,66% |
Contracts Services
1,8
%
| 0 | 1,7 % | 1 | 1,8 % | +41,14% |
Share from Profit of Product Development
0,6
%
| - | - | 0 | 0,6 % | - |
Vendite per regione
USD in Milioni | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
Palestine
100,0
%
| 16 | 71,2 % | 31 | 100,0 % | +87,42% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Bassim Nasr
CEO | Chief Executive Officer | - | 01/01/86 |
Maen Hammoudeh
DFI | Director of Finance/CFO | - | - |
Ayman Qaddumi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tamra Kouba
ADM | Chief Administrative Officer | - | 01/01/98 |
Sandra Nasr
BRD | Director/Board Member | 59 | - |
Sales & Marketing | - | 01/01/17 | |
Foad Qassis
HRO | Human Resources Officer | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Hashim Al-Shawa
BRD | Director/Board Member | 48 | - |
Tawfik Habesch
BRD | Director/Board Member | 62 | - |
Bassim Nasr
CEO | Chief Executive Officer | - | 01/01/86 |
Bassam Yousef
FOU | Founder | 76 | 01/01/86 |
Sandra Nasr
BRD | Director/Board Member | 59 | - |
Director/Board Member | 74 | - | |
Director/Board Member | 50 | - | |
Ramzi Noursi
BRD | Director/Board Member | 55 | - |
Hamza Aloul
BRD | Director/Board Member | 45 | - |
Michael Wirtz
BRD | Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 9 000 000 | 8 909 977 ( 99,00 %) | 0 | 99,00 % |
Coordinate società
![Indirizzo Dar Al-Shifa Pharmaceuticals Company(PHARMACARE)](https://cdn.zonebourse.com/static/address/120970010.png)
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
-.--% | 30,15 Mln | |
+63,05% | 856 Mrd | |
+39,51% | 631 Mrd | |
-4,78% | 359 Mrd | |
+17,52% | 325 Mrd | |
+8,43% | 297 Mrd | |
+5,19% | 234 Mrd | |
+16,30% | 226 Mrd | |
+14,63% | 177 Mrd | |
+1,08% | 165 Mrd |
- Borsa valori
- Azioni
- Azione PHARMACARE
- Società Dar Al-Shifa Pharmaceuticals Company